We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Muscle Pharm Corporation (CE) | USOTC:MSLP | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0002 | 0.00 | 01:00:00 |
|
|
|
Nevada
|
|
77-0664193
|
(State or other jurisdiction of incorporation or
organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
4721 Ironton Street, Building A
Denver, Colorado
|
|
80239
|
(Address of principal executive offices)
|
|
(Zip code)
|
Large accelerated filer
|
[ ]
|
Accelerated filer
|
[ ]
|
Non-accelerated filer
|
[ ] (Do not check if a smaller reporting
company)
|
Smaller reporting company
|
[X]
|
|
|
Emerging growth company
|
[ ]
|
|
|
|
|
|
Page
|
|
|
|
Note About Forward-Looking Statements
|
1
|
|
|
|
|
PART I – FINANCIAL INFORMATION
|
|
|
|
|
|
Item 1.
|
Financial
Statements
|
|
|
|
|
|
Condensed
Consolidated Balance Sheets as of June 30, 2017 (unaudited) and
December 31, 2016
|
2
|
|
|
|
|
Condensed
Consolidated Statements of Operations for the three and six months
ended June 30, 2017 and 2016 (unaudited)
|
3
|
|
|
|
|
Condensed
Consolidated Statements of Comprehensive Loss for the three and six
months ended June 30, 2017 and 2016 (unaudited)
|
4
|
|
|
|
|
Condensed
Consolidated Statement of Changes in Stockholders’ Deficit
for the six months ended June 30, 2017 (unaudited)
|
5
|
|
|
|
|
Condensed
Consolidated Statements of Cash Flows for the six months ended June
30, 2017 and 2016 (unaudited)
|
6
|
|
|
|
|
Notes
to Condensed Consolidated Financial Statements
(unaudited)
|
7
|
|
|
|
Item 2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
26
|
|
|
|
Item 3.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
39
|
|
|
|
Item 4.
|
Controls
and Procedures
|
39
|
|
|
|
PART II – OTHER INFORMATION
|
|
|
|
|
|
Item 1.
|
Legal
Proceedings
|
40
|
|
|
|
Item 1A.
|
Risk
Factors
|
41
|
|
|
|
Item 2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
41
|
|
|
|
Item 3.
|
Defaults
Upon Senior Securities.
|
41
|
|
|
|
Item 4.
|
Mine
Safety Disclosures
|
41
|
|
|
|
Item 5.
|
Other
Information
|
41
|
|
|
|
Item 6.
|
Exhibits
|
41
|
|
|
|
|
Signatures
|
42
|
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
||
|
2017
|
2016
|
2017
|
2016
|
Revenue,
net
|
$
26,192
|
$
32,867
|
$
52,201
|
$
75,779
|
Cost of revenue
(1)
|
18,576
|
22,181
|
38,115
|
49,880
|
Gross
profit
|
7,616
|
10,686
|
14,086
|
25,899
|
Operating
expenses:
|
|
|
|
|
Advertising
and promotion
|
2,240
|
2,686
|
4,128
|
6,973
|
Salaries
and benefits
|
2,620
|
3,292
|
5,889
|
12,912
|
Selling,
general and administrative
|
2,829
|
4,424
|
5,715
|
8,667
|
Research
and development
|
152
|
531
|
289
|
1,394
|
Professional
fees
|
727
|
1,742
|
1,609
|
3,130
|
Restructuring
and other charges
|
—
|
(4,820
)
|
—
|
(4,246
)
|
Settlement
of obligation
|
1,453
|
—
|
1,453
|
—
|
Impairment
of assets
|
—
|
4,313
|
—
|
4,313
|
Total
operating expenses
|
10,021
|
12,168
|
19,083
|
33,143
|
Loss
from operations
|
(2,405
)
|
(1,482
)
|
(4,997
)
|
(7,244
)
|
Gain
on settlement of accounts payable
|
22
|
—
|
471
|
—
|
Loss
on sale of subsidiary
|
—
|
(2,115
)
|
—
|
(2,115
)
|
Other
expense, net (Note 7)
|
(690
)
|
(592
)
|
(1,668
)
|
(1,304
)
|
Loss
before provision for income taxes
|
(3,073
)
|
(4,189
)
|
(6,194
)
|
(10,663
)
|
Provision
for income taxes
|
76
|
7
|
104
|
138
|
Net
loss
|
$
(3,149
)
|
$
(4,196
)
|
$
(6,298
)
|
$
(10,801
)
|
|
|
|
|
|
Net
loss per share, basic and diluted
|
$
(0.23
)
|
$
(0.30
)
|
$
(0.46
)
|
$
(0.78
)
|
|
|
|
|
|
Weighted
average shares used to compute net loss per share, basic and
diluted
|
13,845,301
|
13,874,209
|
13,809,603
|
13,855,754
|
|
Three Months
Ended June 30,
|
Six Months
Ended June 30,
|
||
|
2017
|
2016
|
2017
|
2016
|
Net
loss
|
$
(3,149
)
|
$
(4,196
)
|
$
(6,298
)
|
$
(10,801
)
|
Other
comprehensive loss:
|
|
|
|
|
Change
in foreign currency translation adjustment
|
11
|
11
|
17
|
6
|
Comprehensive
loss
|
$
(3,138
)
|
$
(4,185
)
|
$
(6,281
)
|
$
(10,795
)
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
Additional
|
|
Other
|
|
Total
|
|
Common Stock
|
Paid-in
|
Treasury
|
Comprehensive
|
Accumulated
|
Stockholders’
|
|
|
Shares
|
Amount
|
Capital
|
Stock
|
Loss
|
Deficit
|
Deficit
|
Balance—December
31, 2016
|
14,111,609
|
$
14
|
$
156,301
|
$
(10,039
)
|
$
(162
)
|
$
(150,994
)
|
$
(4,880
)
|
Stock-based
compensation related to issuance and amortization of restricted
stock awards to employees, executives and directors
|
370,162
|
—
|
1,064
|
—
|
—
|
—
|
1,064
|
Stock-based
compensation related to issuance of stock options to an executive
and a director
|
—
|
—
|
83
|
—
|
—
|
—
|
83
|
Change
in foreign currency translation adjustment
|
—
|
—
|
—
|
—
|
17
|
—
|
17
|
Net
loss
|
—
|
—
|
—
|
—
|
—
|
(6,298
)
|
(6,298
)
|
Balance—June
30, 2017
|
14,481,771
|
$
14
|
$
157,448
|
$
(10,039
)
|
$
(145
)
|
$
(157,292
)
|
$
(10,014
)
|
|
Six Months Ended June 30,
|
|
|
2017
|
2016
|
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
|
|
Net
loss
|
$
(6,298
)
|
$
(10,801
)
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|
|
Depreciation
and amortization
|
790
|
1,232
|
Gain
on settlement of accounts payable
|
(471
)
|
—
|
Loss
on sale of subsidiary
|
—
|
2,115
|
Impairment
of assets
|
—
|
4,313
|
Inventory
write down related to restructuring
|
—
|
2,169
|
Non-cash
restructuring and other charges (reversals)
|
—
|
(4,607
)
|
Amortization
of prepaid stock compensation
|
—
|
938
|
Amortization
of prepaid sponsorship and endorsement fees
|
—
|
844
|
Stock-based
compensation
|
1,148
|
5,097
|
Other
|
819
|
156
|
Changes
in operating assets and liabilities:
|
|
|
Accounts
receivable
|
(120
)
|
952
|
Inventory
|
2,465
|
1,359
|
Prepaid
giveaways
|
70
|
196
|
Prepaid
expenses and other current assets
|
(677
)
|
(260
)
|
Other
assets
|
—
|
(55
)
|
Accounts
payable and accrued liabilities
|
530
|
(1,173
)
|
Accrued
restructuring charges
|
(73
)
|
(3,161
)
|
Net
cash used in operating activities
|
(1,817
)
|
(686
)
|
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
|
|
Purchase
of property and equipment
|
—
|
(378
)
|
Proceeds
from sale of subsidiary
|
—
|
5,942
|
Proceeds
from disposal of property and equipment
|
—
|
40
|
Trademark
registrations
|
—
|
(154
)
|
Net
cash provided by investing activities
|
—
|
5,450
|
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
|
|
Proceeds
from secured borrowing arrangement, net of reserves
|
12,116
|
38,041
|
Payments
on secured borrowing arrangement, net of fees
|
(11,650
)
|
(30,791
)
|
Payments
on line of credit
|
—
|
(3,000
)
|
Repayments
of term loan
|
—
|
(2,949
)
|
Repayment
of capital lease and other obligations
|
(63
)
|
(81
)
|
Net
cash provided by financing activities
|
403
|
1,220
|
Effect
of exchange rate changes on cash
|
24
|
(13
)
|
NET
CHANGE IN CASH
|
(1,390
)
|
5,971
|
CASH
— BEGINNING OF PERIOD
|
4,943
|
7,081
|
CASH
— END OF PERIOD
|
$
3,553
|
$
13,052
|
SUPPLEMENTAL
DISCLOSURE OF CASH FLOW INFORMATION:
|
|
|
Cash
paid for interest
|
$
1,086
|
$
926
|
Cash
paid for taxes
|
$
62
|
$
113
|
SUPPLEMENTAL
DISCLOSURE OF NON-CASH ACTIVITIES:
|
|
|
Property
and equipment acquired in conjunction with capital
leases
|
$
12
|
$
24
|
Shares
of common stock issued for BioZone disposition
|
$
—
|
$
640
|
Purchase
of property and equipment included in current
liabilities
|
$
—
|
$
40
|
|
Percentage of Net Revenue
for the Three Months Ended
June 30,
|
Percentage of Net Revenue
for the Six Months Ended
June 30,
|
||
|
2017
|
2016
|
2017
|
2016
|
Customers
|
|
|
|
|
Costco
Wholesale Corporation
|
17
%
|
25
%
|
26
%
|
20
%
|
Amazon
|
12
%
|
*
|
*
|
*
|
GNC
Holdings Inc.
|
*
|
10
%
|
*
|
11
%
|
Bodybuilding.com
|
*
|
*
|
*
|
10
%
|
Cash
proceeds from sale
|
$
5,942
|
Consideration
for common stock transferred
|
50
|
Prepaid
inventory
|
2,000
|
Fair
market value of the common stock transferred
|
(640
)
|
Assets
sold:
|
|
Accounts
receivable, net
|
(923
)
|
Inventory,
net
|
(1,761
)
|
Fixed
assets, net
|
(2,003
)
|
Intangible
assets, net
|
(5,657
)
|
All
other assets
|
(41
)
|
Liabilities
transferred
|
1,197
|
Transaction
and other costs
|
(279
)
|
Loss
on sale of subsidiary
|
$
(2,115
)
|
|
Contract Termination Costs
|
Purchase Commitment of Discontinued Inventories Not Yet
Received
|
Abandoned Lease Facilities
|
Total
|
Balance
as of December 31, 2016
|
$
308
|
$
175
|
$
339
|
$
822
|
Expensed
|
—
|
—
|
—
|
—
|
Cash
payments
|
—
|
—
|
(73
)
|
(73
)
|
Balance
as of June 30, 2017
|
$
308
|
$
175
|
$
266
|
$
749
|
|
As of
June 30,
2017
|
As of
December 31,
2016
|
Finished
goods
|
$
6,133
|
$
8,568
|
Inventory
|
$
6,133
|
$
8,568
|
|
As of
June 30,
2017
|
As of
December 31,
2016
|
Furniture,
fixtures and equipment
|
$
3,598
|
$
3,521
|
Leasehold
improvements
|
2,504
|
2,504
|
Manufacturing
and lab equipment
|
3
|
3
|
Vehicles
|
86
|
334
|
Displays
|
484
|
483
|
Website
|
462
|
462
|
Construction
in process
|
—
|
55
|
Property
and equipment, gross
|
7,137
|
7,362
|
Less:
accumulated depreciation and amortization
|
(4,639
)
|
(4,119
)
|
Property
and equipment, net
|
$
2,498
|
$
3,243
|
|
As of December 31, 2016
|
|||
|
Gross Value
|
AccumulatedAmortization
|
NetCarryingValue
|
Remaining Weighted-AverageUseful Lives(years)
|
Amortized Intangible Assets
|
|
|
|
|
Brand
|
$
2,244
|
$
(606
)
|
$
1,638
|
5.1
|
Total
intangible assets
|
$
2,244
|
$
(606
)
|
$
1,638
|
|
For the Year Ending December 31,
|
|
Remainder
of 2017
|
$
161
|
2018
|
321
|
2019
|
321
|
2020
|
321
|
2021
|
321
|
Thereafter
|
33
|
Total
amortization expense
|
$
1,478
|
|
For the
Three Months
Ended June 30,
|
For the
Six Months
Ended June 30,
|
||
|
2017
|
2016
|
2017
|
2016
|
Other
expense, net:
|
|
|
|
|
Interest
expense, related party
|
$
(587
)
|
$
(121
)
|
$
(1,163
)
|
$
(242
)
|
Interest
expense, other
|
(3
)
|
(84
)
|
(8
)
|
(128
)
|
Interest
expense, secured borrowing arrangement
|
(121
)
|
(273
)
|
(225
)
|
(627
)
|
Foreign
currency transaction gain
|
45
|
91
|
33
|
194
|
Other
|
(24
)
|
(205
)
|
(305
)
|
(501
)
|
Total
other expense, net
|
$
(690
)
|
$
(592
)
|
$
(1,668
)
|
$
(1,304
)
|
|
As of
June 30,
2017
|
As of
December 31,
2016
|
2015
Convertible Note due November 2017 with a related
party
|
$
6,000
|
$
6,000
|
2016
Convertible Note due November 2017 with a related party, net of
discount
|
10,772
|
10,465
|
Obligations
under secured borrowing arrangement
|
3,147
|
2,681
|
Total
debt
|
19,919
|
19,146
|
Less:
current portion
|
(19,919
)
|
(19,146
)
|
Long
term debt
|
$
—
|
$
—
|
For the Year Ending December 31,
|
|
Remainder
of 2017
|
$
219
|
2018
|
419
|
2019
|
392
|
2020
|
268
|
Total
minimum lease payments
|
$
1,298
|
For the Year Ending December 31,
|
|
Remainder
of 2017
|
$
75
|
2018
|
136
|
2019
|
101
|
2020
|
50
|
Total
minimum lease payments
|
362
|
Less
amounts representing interest
|
(23
)
|
Present
value of minimum lease payments
|
$
339
|
Transaction Type
|
Quantity (Shares)
|
Valuation
($)
|
Range of
Value per
Share
|
Stock
issued to employees, executives and directors
|
370,162
|
$
730
|
$
1.97
|
Total
|
370,162
|
$
730
|
$
1.97
|
Transaction Type
|
Quantity
(Shares)
|
Valuation
($)
|
Range of Value per Share
|
Stock
issued to employees, executives and directors
|
179,140
|
$
1,142
|
$1.89-2.95
|
Stock
issued related to sale of subsidiary
|
200,000
|
640
|
3.20
|
Cancellation
of executive restricted stock
|
(333,000
)
|
—
|
12.50
|
Total
|
46,140
|
$
1,782
|
$1.89-12.50
|
|
Unvested Restricted Stock Awards
|
|
|
Number of
Shares
|
Weighted Average
Grant
Date
Fair
Value
|
Unvested
balance – December 31, 2016
|
378,425
|
$
3.45
|
Granted
|
370,162
|
1.97
|
Vested
|
(140,587
)
|
2.58
|
Cancelled
|
—
|
—
|
Unvested
balance – June 30, 2017
|
608,000
|
2.75
|
|
For the Six Months Ended
June 30, 2016
|
Expected
term of options
|
6.5
years
|
Expected
volatility
|
131.0
%
|
Risk-free
interest rate
|
1.71
%
|
Expected
dividend yield
|
0.0
%
|
|
For the Three
Months Ended
June 30,
|
|
|
|
|
2017
|
2016
|
$ Change
|
% Change
|
|
($ in
thousands)
|
|
|
|
Revenue,
net
|
$
26,192
|
$
32,867
|
$
(6,675
)
|
(20.3
)%
|
Cost of revenue
(1)
|
18,576
|
22,181
|
(3,605
)
|
(16.3
)
|
Gross
profit
|
7,616
|
10,686
|
(3,070
)
|
(28.7
)
|
Operating
expenses:
|
|
|
|
|
Advertising
and promotion
|
2,240
|
2,686
|
(446
)
|
(16.6
)
|
Salaries
and benefits
|
2,620
|
3,292
|
(672
)
|
(20.4
)
|
Selling,
general and administrative
|
2,829
|
4,424
|
(1,595
)
|
(36.1
)
|
Research
and development
|
152
|
531
|
(379
)
|
(71.4
)
|
Professional
fees
|
727
|
1,742
|
(1,015
)
|
(58.3
)
|
Restructuring
and other charges
|
—
|
(4,820
)
|
4,820
|
100.0
|
Settement
of obligation
|
1,453
|
—
|
1,453
|
100.0
|
Impairment
of assets
|
—
|
4,313
|
(4,313
)
|
(100.0
)
|
Total
operating expenses
|
10,021
|
12,168
|
(2,147
)
|
(17.6
)
|
Loss
from operations
|
(2,405
)
|
(1,482
)
|
(923
)
|
(62.3
)
|
Gain
on settlement of accounts payable
|
22
|
—
|
22
|
100.0
|
Loss
on sale of subsidiary
|
—
|
(2,115
)
|
2,115
|
100.0
|
Other
expense, net
|
(690
)
|
(592
)
|
(98
)
|
(16.6
)
|
Loss
before provision for income taxes
|
(3,073
)
|
(4,189
)
|
1,116
|
26.6
|
Provision
for income taxes
|
76
|
7
|
69
|
985.7
|
Net
loss
|
$
(3,149
)
|
$
(4,196
)
|
$
1,047
|
25.0
%
|
|
For the
Three Months
Ended June 30,
|
For the
Six Months
Ended June 30,
|
||
|
2017
|
2016
|
2017
|
2016
|
Other
expense, net:
|
|
|
|
|
Interest
expense, related party
|
$
(587
)
|
$
(121
)
|
$
(1,163
)
|
$
(242
)
|
Interest
expense, other
|
(3
)
|
(84
)
|
(8
)
|
(128
)
|
Interest
expense, secured borrowing arrangement
|
(121
)
|
(273
)
|
(225
)
|
(627
)
|
Foreign
currency transaction gain
|
45
|
91
|
33
|
194
|
Other
|
(24
)
|
(205
)
|
(305
)
|
(501
)
|
Total
other expense, net
|
$
(690
)
|
$
(592
)
|
$
(1,668
)
|
$
(1,304
)
|
|
Payments Due by Period
|
||||
|
1 Year
|
2 to 3 Years
|
4 to 5 Years
|
Thereafter
|
Total
|
|
(in
thousands)
|
||||
Operating lease obligations
(1)
|
$
426
|
$
872
|
$
—
|
$
—
|
$
1,298
|
Capital
lease obligations
|
150
|
213
|
—
|
—
|
363
|
Secured
borrowing arrangement
|
3,147
|
—
|
—
|
—
|
3,147
|
Convertible notes with a related
party
(2)
|
17,619
|
—
|
—
|
—
|
17,619
|
Restructuring
liability
|
588
|
161
|
—
|
—
|
749
|
Settlement
obligation
|
1,000
|
2,000
|
—
|
—
|
3,000
|
Other contractual obligations
(3)
|
3,114
|
2,622
|
—
|
—
|
5,736
|
Total
|
$
26,044
|
$
5,868
|
$
—
|
$
—
|
$
31,912
|
|
|
Three Months Ended
|
|
Three Months Ended
|
||||
|
Six Months Ended
June 30, 2017
|
June 30, 2017
|
Mar. 31, 2017
|
Year Ended
Dec. 31, 2016
|
Dec. 31, 2016
|
Sept. 30, 2016
|
June 30, 2016
|
Mar. 31, 2016
|
Net
loss
|
$
(6,298
)
|
$
(3,149
)
|
$
(3,149
)
|
$
(3,477
)
|
$
8,771
|
$
(1,447
)
|
$
(4,196
)
|
$
(6,605
)
|
|
|
|
|
|
|
|
|
|
Stock-based
compensation
|
1,148
|
541
|
607
|
5,304
|
323
|
(116
)
|
427
|
4,670
|
Restructuring
and asset impairment charges
|
—
|
—
|
—
|
3,186
|
(970
)
|
1,920
|
—
|
2,236
|
Gain
on settlement of accounts payable
|
(471
)
|
(22
)
|
(449
)
|
(9,927
)
|
(9,927
)
|
—
|
—
|
—
|
Loss
on sale of subsidiary
|
—
|
—
|
—
|
2,115
|
—
|
—
|
2,115
|
—
|
Amortization
of prepaid sponsorship fees
|
255
|
110
|
145
|
1,235
|
180
|
211
|
146
|
698
|
Other
expense, net
|
1,668
|
690
|
978
|
2,313
|
887
|
122
|
592
|
712
|
Amortization
of prepaid stock compensation
|
—
|
—
|
—
|
938
|
—
|
—
|
235
|
703
|
Depreciation
and amortization of property and equipment
|
630
|
290
|
340
|
1,551
|
389
|
346
|
389
|
427
|
Amortization
of intangible assets
|
160
|
80
|
80
|
576
|
80
|
80
|
196
|
220
|
(Recovery)
provision for doubtful accounts
|
224
|
144
|
80
|
386
|
152
|
225
|
43
|
(34
)
|
Issuance
of common stock warrants to third parties for services
|
—
|
—
|
—
|
6
|
—
|
—
|
3
|
3
|
Provision
for income taxes
|
104
|
76
|
28
|
318
|
180
|
—
|
7
|
131
|
Adjusted
EBITDA
|
$
(2,580
)
|
$
(1,240
)
|
$
(1,340
)
|
$
4,524
|
$
65
|
$
1,341
|
$
(43
)
|
$
3,161
|
|
|
|
|
Incorporated by Reference
|
||||||
ExhibitNo.
|
|
Description
|
|
Form
|
|
SEC File
Number
|
|
Exhibit
|
|
Filing Date
|
10.1
**
|
|
Amended and Restated Executive Employment
Agreement, dated as of January
14, 2017, between the Company and Ryan
Drexler.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
**
|
|
Certification
of the Chief Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.2
**
|
|
Certification
of the Chief Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.1
***
|
|
Certification
of the Chief Executive Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.2
***
|
|
Certification
of the Chief Financial Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101**
|
|
The following materials from MusclePharm Corporation’s
quarterly report on Form 10-Q for the six months ended June 30,
2017 formatted in XBRL (eXtensible Business Reporting Language):
(i) the Condensed Consolidated Balance Sheets; (ii) the Condensed
Consolidated Statements of Operations; (iii) the Condensed
Consolidated Statements of Comprehensive Income; (iii) the
Condensed Consolidated Statements of Changes in Stockholders’
Equity (Deficit); (iv) the Condensed Consolidated Statements of
Cash Flows; and (v) related notes to these financial
statements.
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUSCLEPHARM CORPORATION
|
|
|
|
|
|
Date: August 14, 2017
|
|
By:
|
/s/ Ryan Drexler
|
|
|
Name:
|
Ryan Drexler
|
|
|
Title:
|
Chief Executive Officer, President and Chairman
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
By:
|
/s/ Paul Anton
|
|
|
Name:
|
Paul Anton
|
|
|
Title:
|
Vice President of Finance and Administration
|
|
|
|
(Principal Financial Officer)
|
|
|
|
(Principal Accounting Officer)
|
1 Year Muscle Pharm (CE) Chart |
1 Month Muscle Pharm (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions